Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Clinical Breast Cancer|November 21, 2007
Ixabepilone, first in a new class of antineoplastic agents: the natural epothilones and their analoguesMonica N FornierClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Microtubule active agents: beyond the taxane frontierPatrick G Morris, Monica N FornierExpert Review of Anticancer Therapy|February 6, 2009
Novel anti-tubulin cytotoxic agents for breast cancerPatrick G Morris, Monica N FornierCritical Reviews in Oncology/Hematology|March 16, 2010
Optimizing the use of anthracyclines in older patients with breast cancerPatrick G Morris, Monica N FornierClinical Breast Cancer|September 1, 2010
Algorithms for the treatment of patients with metastatic breast cancer and prior exposure to taxanes and anthracyclinesElizabeth A Comen, Monica N FornierClinical Advances in Hematology & Oncology : H&O|April 16, 2009
Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancerPatrick G Morris, Monica N FornierOncology (Williston Park, N.Y.)|December 20, 2003
Risk models for neutropenia in patients with breast cancerChau T Dang, Monica N Fornier, Clifford A HudisHSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|August 23, 2021
Vertebral Fractures After Denosumab Discontinuation in Breast Cancer Survivors: A Single Institution ExperienceMichele Yeung, Kaylee Ho, Monica N Fornier, et al.Cancer|September 1, 2005
Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxaneMonica N Fornier, Shanu Modi, Katherine S Panageas, et al.Pageof 3